Back
Reneo Pharmaceuticals Stock Price Chart
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More
Sell
41
RPHM
Reneo Pharmaceuticals
Last Price:
1.81
Seasonality Move:
-30.28%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in the Next Big AI Disruptor Today
Learn More- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RPHM is experiencing slight buying pressure.
Reneo Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.68 | Buy |
| 20-day SMA: | 1.52 | Buy |
| 50-day SMA: | 1.49 | Buy |
| 200-day SMA: | 1.6 | Buy |
| 8-day EMA: | 1.68 | Buy |
| 20-day EMA: | 1.58 | Buy |
| 50-day EMA: | 1.53 | Buy |
| 200-day EMA: | 2.23 | Sell |
Reneo Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 69.89 | Buy |
| Chaikin Money Flow: | 115528 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.38 - 1.64) | Buy |
| Bollinger Bands (100): | (1.42 - 1.68) | Buy |
Reneo Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reneo Pharmaceuticals Stock
Is Reneo Pharmaceuticals Stock a Buy?
- Reneo Pharmaceuticals share price is 1.82 while RPHM 8-day simple moving average is 1.68, which is a Buy signal.
- The stock price of RPHM is 1.82 while Reneo Pharmaceuticals 20-day SMA is 1.52, which makes it a Buy.
- Reneo Pharmaceuticals 50-day simple moving average is 1.49 while RPHM share price is 1.82, making it a Buy technically.
- RPHM stock price is 1.82 and Reneo Pharmaceuticals 200-day simple moving average is 1.60, creating a Buy signal.
RPHM Technical Analysis vs Fundamental Analysis
Sell
41
Reneo Pharmaceuticals (RPHM)
is a Sell
Is Reneo Pharmaceuticals a Buy or a Sell?
-
Reneo Pharmaceuticals stock is rated a Sell
The current Reneo Pharmaceuticals [RPHM] share price is $1.82. The Score for RPHM is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Reneo Pharmaceuticals Stock Info
Market Cap:
60.84M
Price in USD:
1.82
Share Volume:
423.6K
Reneo Pharmaceuticals 52-Week Range
52-Week High:
9.21
52-Week Low:
0.98
Sell
41
Reneo Pharmaceuticals (RPHM)
is a Sell
Reneo Pharmaceuticals Share Price Forecast
-
What is the Reneo Pharmaceuticals stock price today?
The Reneo Pharmaceuticals stock price is 1.82 USD today. -
Will RPHM stock go up or go down?
Reneo Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Reneo Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reneo Pharmaceuticals is overvalued.
Is Reneo Pharmaceuticals Stock a Buy?
- Reneo Pharmaceuticals share price is 1.82 while RPHM 8-day exponential moving average is 1.68, which is a Buy signal.
- The stock price of RPHM is 1.82 while Reneo Pharmaceuticals 20-day EMA is 1.58, which makes it a Buy.
- Reneo Pharmaceuticals 50-day exponential moving average is 1.53 while RPHM share price is 1.82, making it a Buy technically.
- RPHM stock price is 1.82 and Reneo Pharmaceuticals 200-day simple moving average is 2.23, creating a Sell signal.
Fundamental Analysis of Reneo Pharmaceuticals
Is Reneo Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Reneo Pharmaceuticals
Should I short Reneo Pharmaceuticals stock?
- RPHM Moving Average Covergence Divergence (MACD) indicator is 0.07, suggesting Reneo Pharmaceuticals is a Buy
- Reneo Pharmaceuticals Relative Strength Index (RSI) is 69.89, which suggest Reneo Pharmaceuticals is overbought
- The Bollinger Bands (25) for Reneo Pharmaceuticals is (1.38 - 1.64), which suggest Reneo Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Reneo Pharmaceuticals is (1.42 - 1.68), which suggest Reneo Pharmaceuticals is a Buy
* Reneo Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.